Found 0 matching trials
Pilot Open Label Use of the Hi-OXSR for the Treatment of Post COVID-19 Cognitive Dysfunction PHASE1 During the worldwide COVID-19 pandemic a large number patients reported dif...
Show More Location
University Health Network
Learn More & Join Trial
Efficacy of High Dose Dual Therapy, Sequential Therapy and Triple Therapy in H. Pylori Eradication PHASE4 Up to now, to our knowledge, there is few randomized, large scale study pro...
Show More Location
National Taiwan University Hospital
Learn More & Join Trial
Efficacy of 10-day and 14-day Sequential Therapy Versus Triple Therapy on the Eradication of Helicobacter Pylori PHASE4 Background: Helicobacter pylori infection has been shown to be associated w...
Show More Location
National Taiwan University Hospital
Learn More & Join Trial
Lactoferrin in Helicobacter Pylori Eradication Either With Standard Triple Therapy or Sequential Therapy PHASE4 The investigators aim at evaluating the efficacy of bovine lactoferrin addi...
Show More Location
Faculty of Medicine
Learn More & Join Trial
A Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection PHASE4 The purpose of this study is to assess efficacy of a new 14-day sequential ...
Show More Learn More & Join Trial
MEXIDOL® Sequential Therapy of Patients With Primary Open-angle Glaucoma (POAG) PHASE4 Hypothesis: The use of neurocytoprotectors helps restore the functional act...
Show More Location
Tyumen Scientific Center of the Russian Academy of Sciences
Learn More & Join Trial
Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer PHASE2 To observe the efficacy and safety of hydrochloride anlotinib combined with...
Show More Location
Multiple Locations
Learn More & Join Trial
Sequential FDG-PET and miRNA as Biomarkers of Preoperative Treatment Strategy in LA Oesophago-Gastric Cancer PHASE2 GastroPET is a prospective, multicenter, non-randomized interventional stud...
Show More Location
Masaryk Memorial Cancer Institute
Learn More & Join Trial
A Clinical Study To Evaluate Camrelizumab (SHR-1210) Plus Capecitabine and Oxaliplatin Followed by Sequential Treatment With Camrelizumab Plus Apatinib Mesylate in Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJ) Without Prior Systemic Therapy PHASE3 This is a randomized, open-label, multi-center, phase III trial to evaluate...
Show More Location
Beijing Cancer Hospital, Peking University
Learn More & Join Trial
Azithromycin - Ivermectin Mass Drug Administration for Skin Disease PHASE4 This is an open-label prospective community intervention trial to assess th...
Show More Location
Atoifi Adventist Hospital
Learn More & Join Trial